Loading chat...

MO HB3173

Bill

Status

Introduced

2/3/2026

Primary Sponsor

Carolyn Caton

Click for details

Origin

House of Representatives

2026 Regular Session

AI Summary

  • Prohibits knowingly possessing, preparing, selling, distributing, or advertising mitragynine-derived products in Missouri

  • Defines "mitragynine-derived product" as any product containing mitragynine pseudoindoxyl or containing 7-hydroxymitragynine (7-OH) at levels greater than 2% of the overall alkaloid composition

  • Covers 7-OH regardless of whether naturally extracted or synthetically produced, including all isomers, esters, ethers, and salts

  • Exempts research institutions (higher education institutions and entities conducting scientific or medical research) from the prohibition

  • Adds new section 196.1172 to Chapter 196 of Missouri Revised Statutes

Legislative Description

Prohibits the possession and sale of certain mitragynine-derived products

Last Action

Action Postponed (H)

3/11/2026

Committee Referrals

Emerging Issues2/9/2026

Full Bill Text

No bill text available